DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 5Dr. Reddy's Laboratories
02 1Supriya Lifescience
03 2Accord Healthcare Pty. Ltd.
04 25Accord healthcare
05 4Accure Labs
06 2Actavis Inc
07 2Alembic Pharmaceuticals Limited
08 1Almaject
09 2Amneal Pharmaceuticals
10 3Aurobindo Pharma Limited
11 2Ayana Pharma
12 6BAXTER HEALTHCARE PTY LTD
13 2Baxter HealthCare South Africa (Pty) Ltd
14 5Baxter Healthcare Corporation
15 5Bayer AG
16 1Bluepharma
17 3Bristol Myers Squibb
18 1CKD Otto Pharma
19 1Central Procurement & Supplies Unit
20 2Cheplapharm Arzneimittel Gmbh
21 2Cipla Medpro South Africa
22 1Copharma Aps
23 1Deva Holding AS
24 1Dr Reddy's Laboratories (Pty) Ltd
25 3EBEWE Pharma Ges.m.b.H Nfg. KG
26 1Eugia Pharma
27 2Flagship Biotech International Pvt. Ltd
28 1Fresenius Kabi USA
29 2Fresenius SE & Co. KGaA
30 1GLAND PHARMA LIMITED
31 6GetWell Pharmaceutical
32 1Health Biotech
33 1Healthcare Pharmaceuticals
34 5Hikma Pharmaceuticals
35 1Intelliscend
36 1JV Healthcare Limited
37 2Janssen-Cilag
38 2Jodas Expoim Pvt. Ltd
39 2Karo Pharma
40 3Key Oncologics
41 2Lupin Ltd
42 3Naprod Life Sciences
43 2Nishchay Pharmaceuticals Pvt. Ltd.
44 4Oethmaan Biosims
45 1PHARMOBEDIENT
46 1Panacea Biotec Limited
47 2Pfizer Consumer Healthcare
48 32Pfizer Inc
49 5Pharmachemie
50 8Pharmachemie (Pty) Ltd
51 1Pharmaplan
52 1Powercliff Limited
53 1Prohealth Limited
54 3SEACROSS PHARMACEUTICALS
55 1STADA Arzneimittel
56 1Sagent Pharmaceuticals
57 3Sakar Healthcare
58 8Sandoz B2B
59 1Sanoswiss Uab
60 10Sun Pharmaceutical Industries Limited
61 1Taro Pharmaceutical Industries
62 1Tedec Meiji Farma
63 15Teva Pharmaceutical Industries
64 4TherDose Pharma
65 6Viatris
66 2Vinkem Labs Ltd
67 1Zhejiang Hisun Pharmaceutical
68 2Zydus Lifesciences
01 2Concentrate For Dispersion For Infusion
02 4Concentrate For Infusion Solution
03 19Concentrate For Solution For Infusion
04 4Concentrate to the infusion fluid
05 1Concentrate to the infusion fluid, resolution
06 1Doxorubicin 100Mg 50Ml 1 Units Parenteral Use
07 6Doxorubicin 10Mg 5Ml 1 Units Parenteral Use
08 3Doxorubicin 200Mg 100Ml 1 Units Parenteral Use
09 1Doxorubicin 20Mg 10Ml 1 Units Parenteral Use
10 1Doxorubicin 50Mg 1 Unit Parenteral Use
11 1Doxorubicin 50Mg 2 Units Parenteral Use
12 4Doxorubicin 50Mg 25Ml 1 Units Parenteral Use
13 11INF
14 23INJ
15 16INJECTABLE, LIPOSOMAL;INJECTION
16 38INJECTABLE;INJECTION
17 6INJECTION
18 1Infusion Dispersion
19 4Injectable Solution
20 1Injectable; Injection
21 23Injection
22 5Injection fluid, resolution
23 1Liposomal Injection
24 1Liposome Injection
25 1Liquid Injection
26 2Lyo.Inj
27 2Lyophilised Injection
28 1POI
29 2POWDER FOR SOLUTION
30 3Powder For Concentrate For Solution For Infusion
31 1Powder For Dispersion Concentrate For Infusion
32 1Powder For Injectable Solution
33 1Powder For Solution For Injection
34 1Powder and liquids to concentrate for infusion, liposomaldispersjon
35 2Powder for injection fluid, resolution
36 2SOL
37 6SOLUTION
38 2SUSPENSION
39 15Solution For Injection
40 1Vial
41 16Blank
01 21Allowed
02 7Approved
03 3Authorised
04 8Authorized
05 1Cancelled
06 22DISCN
07 7Deregistered
08 45Generic
09 2Lead Market Dossiers- Approved in US and Under review in EU
10 1Lead Market Dossiers- Filed
11 6Originator
12 7Prescription
13 32RX
14 4Withdrawn
15 70Blank
01 2ADRIAMYCIN PFS
02 8Adriamycin
03 2Adriblastin RD
04 3Adriblastin Solution
05 5Adriblastina
06 1Adriblastina CSV 10mg/5ml
07 1Adriblastina CSV 50mg/25ml
08 1Adriblastina RD 10mg
09 1Adriblastina RD 50mg
10 1CAELYX
11 11Caelyx
12 3Caelyx Pegylated Liposomal
13 1Celdoxome Pegylated Liposomal
14 1Cipla Doxorubicin 10
15 1Cipla Doxorubicin 50
16 2DOXIL (LIPOSOMAL)
17 1DOXOPEG
18 4DOXORUBA
19 1DOXORUBICIN
20 1DOXORUBICIN -SOL PCH 10MG
21 1DOXORUBICIN 10mg/5ml FRESENIUS
22 1DOXORUBICIN 50mg/25ml FRESENIUS
23 33DOXORUBICIN HYDROCHLORIDE
24 14DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
25 2DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP
26 1DOXORUBICIN HYDROCHLORIDE INJECTION
27 1DOXORUBICIN INJECTION, BP
28 1DOXORUBICIN-SOL PCH 50MG
29 2DOXOTHER
30 1Doxolip
31 1Doxonish 10
32 1Doxonish 50
33 11Doxorubicin
34 1Doxorubicin "Ebewe" 10mg (5ml vial)
35 1Doxorubicin "Ebewe" 50mg (25ml vial)
36 1Doxorubicin - Pch 10
37 2Doxorubicin ACC
38 11Doxorubicin Accord
39 1Doxorubicin Accord 10mg/5ml
40 1Doxorubicin Accord 50mg/25ml
41 2Doxorubicin Accord liposomal
42 2Doxorubicin Actavis
43 1Doxorubicin Aurovitas
44 1Doxorubicin Copharma
45 4Doxorubicin Ebewe
46 2Doxorubicin Mylan
47 1Doxorubicin Mylan Concentrate For Soln For Inf
48 1Doxorubicin Mylan Pdr/Conc/Soln For Infus
49 1Doxorubicin Pch
50 1Doxorubicin Pch 10 10Mg Vial
51 1Doxorubicin Pch 50
52 1Doxorubicin Rtu
53 1Doxorubicin Rtu 10-5 5Ml
54 1Doxorubicin Rtu 200-100 100Ml
55 1Doxorubicin Rtu 50-25 25Ml
56 4Doxorubicin Sandoz eco
57 1Doxorubicin Sanoswiss
58 1Doxorubicin Stada
59 3Doxorubicin Teva
60 1Doxorubicin hcl faulfing powder vial
61 1Doxorubicin-Hexal 10Mg/5Ml
62 1Doxorubicin-Hexal 50Mg/25Ml
63 4Doxorubicin-Teva
64 1Doxorubicina Tedec
65 1Doxred 10 Lyophilized Powder
66 1Doxred 10mg/5ml
67 1Doxred 50 Lyophilized Powder
68 1Doxred 50mg/25ml
69 2Farmiblastina
70 2I-DOX
71 1Kemodoxin
72 6Liposomal Doxorubicin SUN
73 2Myocet
74 2Myocet Liposomal
75 3RUBEX
76 1Ribodoxo
77 1Rubexet 10mg/5ml
78 1Rubexet 200mg/100ml
79 1Rubexet 50mg/25ml
80 1Sopilcin 20 mg/10 ml
81 1TARO-DOXORUBICIN LIPOSOMAL
82 2Zolsketil Pegylated Liposomal
83 29Blank
01 16Australia
02 7Canada
03 35India
04 1Indonesia
05 17Italy
06 7Malta
07 13Norway
08 1Portugal
09 37South Africa
10 9Spain
11 14Sweden
12 21Switzerland
13 1Turkey
14 54USA
15 3United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 20MG/10ML (2MG/ML)
Packaging :
Approval Date : 2017-05-15
Application Number : 208657
Regulatory Info : RX
Registration Country : USA
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 10MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 50MG/25ML (2MG/ML)
Packaging :
Approval Date : 2017-05-15
Application Number : 208657
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 2MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 20MG/10ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 50MG/25ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXIL (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 20MG/10ML (2MG/ML)
Packaging :
Approval Date : 1995-11-17
Application Number : 50718
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXIL (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 50MG/25ML (2MG/ML)
Packaging :
Approval Date : 2000-06-13
Application Number : 50718
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RUBEX
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1989-04-13
Application Number : 62926
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RUBEX
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date : 1989-04-13
Application Number : 62926
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1982-01-01
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date : 1982-01-01
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date : 1985-05-20
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 150MG/VIAL
Packaging :
Approval Date : 1987-07-22
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2MG/ML
Packaging :
Approval Date : 1987-12-23
Application Number : 50629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 200MG/100ML
Packaging :
Approval Date : 1988-05-03
Application Number : 50629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 150MG/75ML
Packaging :
Approval Date : 2011-03-28
Application Number : 50629
Regulatory Info : DISCN
Registration Country : USA
